Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

This example

...

This example shows findings from an assessment of ... a sequence rearrangement with the purpose of determining ...  .

Glenn Barnes -

...

the characteristics of a fusion event between the BRD4 and MYO10 genes. The identifier for the genome reference used to generate the reported result is shown in GFGENREF. 

Dataset wrap
Namegf
Rowcaps
Row 1:

Shows the

variant impact classification, a categorization of the phenotypic or clinical significance of the genomic variation, caused by the

predicted functional impact of the BRD4 and MYO10 sequence rearrangement.

 

Row 2:

Shows the first gene, BRD4, involved in the fusion event. The designation (name or number) of the chromosome on which the variant appears is shown in GFCHROM. The published symbol for the gene of interest is shown in GFSYM. The description of the type of genomic entity that is represented by the published symbol in GFSYM is shown in GFSYMTYP as GENE WITH PROTEIN PRODUCT. The location within a sequence for the observed value in GFORRES is shown in GFGENLOC. 

Row 3:Shows the second gene, MYO10, involved in the fusion event. The designation (name or number) of the chromosome on which the variant appears is shown in GFCHROM. The published symbol for the gene of interest is shown in GFSYM. The description of the type of genomic entity that is represented by the published symbol in GFSYM is shown in GFSYMTYP as GENE WITH PROTEIN PRODUCT. The location within a sequence for the observed value in GFORRES is shown in GFGENLOC. 
Row 4:

Shows the

...

characterization or classification of the structural changes to the genes as a consequence of the sequence rearrangement BRD4 and MYO10 genes.

Row 5:

Shows the predicted effect of the sequence rearrangement on the original reading frames of the

... .

BRD4 and MYO10 genes.

Row 6:Shows the
...
read depth, the total number of times the locus of the fusion event was sequenced.
Dataset2
RowSTUDYIDDOMAINUSUBJIDGFSEQGFGRPIDGFREFIDGFTESTCDGFTESTGFTSTDTLGFORRESGFORRESUGFSTRESCGFSTRESNGFSTRESUGFGENREFGFCHROMGFSYMGFSYMTYPGFGENLOCGFXFNGFNAMGFSPECGFMETHODVISITNUMVISITVISITDYGFDTCGFDY
1GR123GF100001111TRF001338(TBD)SEQREARSequence RearrangementVARIANT

REARRANGEMENT IMPACT CLASSIFICATION

likely pathogenic
likely pathogenic

GRCh37.75



/compbio/analysis/120718_SN855_0084_AD13D5ACXX_LCNL-361/sampleAnalysis/sample18.TRF001338.01/TRF001338.01.vars.final.xmlACME XYZDNATARGETED GENOME SEQUENCING1SCREENING12022-01-252
2GR123GF100001221TRF001338(TBD)SEQREARSequence Rearrangement"REARRANGEMENT PARTNER GENE 1"BRD4
BRD4

GRCh37.7519BRD4GENE WITH PROTEIN PRODUCT15383893-15384049/compbio/analysis/120718_SN855_0084_AD13D5ACXX_LCNL-361/sampleAnalysis/sample18.TRF001338.01/TRF001338.01.vars.final.xmlACME XYZDNATARGETED GENOME SEQUENCING1SCREENING12022-01-252
3GR123GF100001331TRF001338(TBD)SEQREARSequence Rearrangement"REARRANGEMENT PARTNER GENE 2"MYO10
MYO10

GRCh37.755MYO10GENE WITH PROTEIN PRODUCT16724239-16724557/compbio/analysis/120718_SN855_0084_AD13D5ACXX_LCNL-361/sampleAnalysis/sample18.TRF001338.01/TRF001338.01.vars.final.xmlACME XYZDNATARGETED GENOME SEQUENCING1SCREENING12022-01-252
4GR123GF100001441TRF001338(TBD)SEQREARSequence Rearrangement"VARIANT DESCRIPTION"

REARRANGEMENT TYPE

truncation
truncation

GRCh37.75



/compbio/analysis/120718_SN855_0084_AD13D5ACXX_LCNL-361/sampleAnalysis/sample18.TRF001338.01/TRF001338.01.vars.final.xmlACME XYZDNATARGETED GENOME SEQUENCING1SCREENING12022-01-252
5GR123GF100001551TRF001338(TBD)SEQREARSequence Rearrangement"

PREDICTED IN-FRAME

"

INDICATOR

unknown
unknown

GRCh37.75



/compbio/analysis/120718_SN855_0084_AD13D5ACXX_LCNL-361/sampleAnalysis/sample18.TRF001338.01/TRF001338.01.vars.final.xmlACME XYZDNATARGETED GENOME SEQUENCING1SCREENING12022-01-252
6GR123GF100001661TRF001338(TBD)SEQREARSequence RearrangementREAD DEPTH45
4545
GRCh37.75



/compbio/analysis/120718_SN855_0084_AD13D5ACXX_LCNL-361/sampleAnalysis/sample18.TRF001338.01/TRF001338.01.vars.final.xmlACME XYZDNATARGETED GENOME SEQUENCING1SCREENING12022-01-252